Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-09-26

FDA Approved: QVAR REDIHALER — Supplemental Application (Teva Respiratory, LLC)

View source ↗

Summary

FDA approved Teva's supplemental application for QVAR REDIHALER (beclomethasone dipropionate HFA), expanding the approved QVAR inhaled corticosteroid product to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QVAR REDIHALER (Beclomethasone dipropionate HFA)

Snippet

SUPPL AP for QVAR REDIHALER (BECLOMETHASONE DIPROPIONATE HFA)